Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-22

FDA Approved: PROSTIN VR PEDIATRIC — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

FDA approved a supplemental application for PROSTIN VR PEDIATRIC (alprostadil) from Pharmacia & Upjohn Company LLC, updating its pediatric use labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROSTIN VR PEDIATRIC (ALPROSTADIL)

Snippet

SUPPL AP for PROSTIN VR PEDIATRIC (ALPROSTADIL)